Aster DM Healthcare Limited has informed the Exchange regarding a press release dated April 18, 2025, titled "We are pleased to inform you that on April 15, 2025, Competition Commission of India (CCI) has approved the proposed merger between Aster DM Healthcare Limited and Quality Care India Ltd, under Section 31(1) of the Competition Act, 2002.Kindly take the above said information on record as per the requirement of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.".
ASTERDM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Competition Commission of India (CCI) has approved the proposed merger between Aster DM Healthcare and Quality Care India Ltd under Section 31(1) of the Competition Act, 2002, on April 15, 2025. The merged entity, to be called 'Aster DM Quality Care Limited,' will be jointly controlled by Aster Promoters and Blackstone. It will combine four brands—Aster DM, CARE Hospitals, KIMSHEALTH, and Evercare—creating a network of 38 hospitals and over 10,150 beds across 27 cities, making it one of the top 3 hospital chains in India. The combined entity is expected to grow to approximately 13,300 beds by FY27 through a mix of greenfield and brownfield expansion. The merger transaction is expected to be completed during 2025.
This is a key regulatory milestone for shareholders, removing a major hurdle for the merger's completion expected this year. The combined scale, expected synergies, and growth pipeline to ~13,300 beds by FY27 could strengthen the company's market position and long-term earnings potential, though actual benefits depend on smooth integration.